Evidence map›Paper›PMID 34243059›Full record

ArticleJournal of affective disorders2021

Moderators of a resiliency group intervention for frontline clinicians during the COVID-19 pandemic.

Louisa G Sylvia, Nevita George, Dustin J Rabideau, Joanna M Streck, Evan Albury, Daniel L Hall, Christina M Luberto, Helen R Mizrach, Giselle K Perez, Sydney Crute and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of affective disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Louisa G SylviaMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA. Electronic address: lsylvia2@mgh.harvard.edu.
Nevita GeorgeMassachusetts General Hospital, Boston, MA, USA; Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA.
Dustin J RabideauMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Joanna M StreckMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Evan AlburyMassachusetts General Hospital, Boston, MA, USA; Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA.
Daniel L HallMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
Christina M LubertoMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
Helen R MizrachMassachusetts General Hospital, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
Giselle K PerezMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
Sydney CruteMassachusetts General Hospital, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
Darshan H MehtaMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
Mary Susan ConveryMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
Sara E LoobyMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Gregory FricchioneMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
Maurizio FavaMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Sabine WilhelmMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Elyse R ParkMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.

Funding

Career Development Program in Substance Use and Addiction MedicineK12DA043490 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI A EDEN EVINS, NANCY A RIGOTTI · 2017 to 2026
$4.7M
A Multimodal Mind-Body Intervention for Fear of Recurrence among Cancer SurvivorsK23AT010157 · NCCIH · MASSACHUSETTS GENERAL HOSPITAL · PI HALL, DANIEL LEE · 2019 to 2023
$785k
NCCIH NIH HHS K23 AT010157NIDA NIH HHS K12 DA043490
6 · The paper itself

Abstract

backgroundTo mitigate the psychological burdens of COVID-19 for frontline clinicians (FCs), we adapted an existing evidence-based resiliency program, Stress Management and Resilience Training Relaxation Response Program (SMART-3RP), for FCs. This analysis explores moderators of stress coping to determine which subgroups of FCs benefited most from SMART-3RP.

methods102 FCs from Mass General Brigham hospitals engaged in the adapted SMART-3RP. Assessments were completed at group entry (Week 0) and completion (Week 4). The primary outcome was stress coping, and we examined 15 possible baseline moderators. We fit linear mixed effects regression models and assessed potential baseline moderators using a likelihood ratio test. We report model-based estimates and confidence intervals for each moderator-by-time interaction (i.e., differential effect), where positive/negative values indicate more/less improvement in average perceived stress coping.

resultsStress coping improved from Week 0 to Week 4 (mean improvement [95% CI] = 0.9 [0.6 to 1.2]). FCs with higher anxiety (differential effect [95% CI] = 0.3 [0.1 to 0.4]), depression (0.4 [0.2 to 0.6]), and loneliness (0.4 [0.1 to 0.6]), but lower levels of mindfulness (CAMS-R DISCUSSION: Results highlight particular sub-populations of FCs that may benefit more from a stress management intervention, especially during emergency responses (e.g., COVID-19 pandemic).

Indexed as

COVID-19Resilience, PsychologicalAdaptation, PsychologicalHumansPandemicsSARS-CoV-2Stress, PsychologicalCOVID-19 pandemicFrontline cliniciansResiliency programStress coping

Identifiers

PMID34243059
PMCPMC8712555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.